WebCorporate Office Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad Telangana 500034, INDIA Tel: +91.40.4900 2900 WebJan 31, 2016 · 2. Chairman - Dr. K.Angi Reddy. 3. Dr.Reddy’s Lab Ltd • Type Public • Traded as NSE: DRREDDY BSE: 500124 NYSE: RDY • Industry Pharmaceuticals • Founded1984 • Headquarters Hyderabad, …
Dr. Reddy
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medicatio… WebDr. Reddy's Laboratories 884,487 followers on LinkedIn. We accelerate access to affordable and innovative medicines because Good Health Can’t Wait. Dr. Reddy’s … branchburg gym
Senior Director - SCM - Dr. Reddy
WebWe started in 1984 with a modest investment and a bold vision. Today, with research and development centres, manufacturing facilities and commercial. presence across the … Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company … Talented people have played a major role in powering and defining the growth of Dr. … From supporting a hospital for the elderly, to setting up the Dr. Reddy’s Foundation … Corporate Office Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, … For any Dr. Reddy’s product availability related issues, please contact us: … WebDr. Reddy's Laboratories Ltd. 7-1-27, Ameerpet Hyderabad, Andhra Pradesh 500 016 India Telephone: 91-40-373-1946 Fax: 91-40-373-1955 Web site: http://www.drreddys.com. Public Company Incorporated: 1984 Employees: 5,796 Sales: Rs 18.01 billion ($391.8 million) (2003) Stock Exchanges: Bombay New York Ticker Symbol: RDY NAIC: 325412 … WebDr. Reddy's Laboratories Ltd. Committed grants. More in this section ... Dr. Reddy's Laboratories Ltd. Grantee website Hyderabad, Telangana, India Purpose. to accelerate the manufacturing and availability of a low-cost COVID therapeutic to populations in low- and middle-income countries Grantee. Division. Global Health ... hageseth v. superior court